학술논문
Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study)
Document Type
Article
Author
Welte, T.; Dellinger, R.P.; Ebelt, H.; Werdan, K.; Nuding, S.; Ferrer, M.; Opal, S.M.; Singer, M.; Vincent, J.-L.; Martin-Loeches, I.; Artigas, A.; Almirall, J.; Ignacio Ayestarán, J.; Ferrer, R.; Sirgo Rodríguez, G.; Shankar-Hari, M.; Álvarez-Lerma, F.; Riessen, R.; Sirvent, J.-M.; Kluge, S.; Zacharowski, K.; Bonastre Mora, J.; Lapp, H.; Wöbker, G.; Achtzehn, U.; Brealey, D.; Kempa, A.; Sánchez García, M.; Brederlau, J.; Kochanek, M.; Reschreiter, H.P.; Wise, M.P.; Belohradsky, B.H.; Bobenhausen, I.; Dälken, B.; Dubovy, P.; Langohr, P.; Mayer, M.; Schüttrumpf, J.; Wartenberg-Demand, A.; Wippermann, U.; Wolf, D.; Torres, A.
Source
In: Intensive Care Medicine . (Intensive Care Medicine, 1 April 2018, 44(4):438-448)
Subject
Language
English
ISSN
14321238
03424642
03424642